SPARC and prostate carcinoma: Enriquez et al (31) suggests that ADT leads to downregulation of the stromal cell protein SPARC in stromal cells, and that downregulation of SPARC causes stromal cells to release IL6, which is a NED inducer that drives neuroendocrine differentiation in prostate cancer.